VIM
REGN icon

Vancity Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Vancity Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,213
Closed -$4.59M – 65
2021
Q2 		$4.59M Sell
8,213
-10,994
-57% -$5.57M 0.64% 55
2021
Q1 		$9.09M Buy
19,207
+5,687
+42% +$2.77M 1.67% 22
2020
Q4 		$6.53M Buy
+13,520
New +$7.3M 1.3% 33

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vancity Investment Management's REGN Position: Q3 2021 in Review

Vancity Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2021, closing a stake of 8,213 shares — an estimated $4.59M sold.

Vancity Investment Management first reported a position in REGN in Q4 2020 and held it in 3 quarters. The position peaked at $9.09M in Q1 2021. 1,018 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

  • Vancity Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Vancity Investment Management sold 8,213 Regeneron Pharmaceuticals shares in Q3 2021, an estimated $4.59M.
  • Vancity Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Vancity Investment Management's Regeneron Pharmaceuticals position peaked at $9.09M in Q1 2021.
  • 1,018 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on Vancity Investment Management's 13F filing for Q3 2021, filed 7 Oct 2021.